(Q35893645)

11 August 2017

1 reference

title

The road to tolerance: renal transplant tolerance induction in nonhuman primate studies and clinical trials (English)

1 reference

11 August 2017

Eric A Elster

1

1 reference

11 August 2017

Douglas A Hale

2

1 reference

11 August 2017

Roslyn B Mannon

3

1 reference

11 August 2017

Linda C Cendales

4

1 reference

11 August 2017

S John Swanson

5

1 reference

11 August 2017

Allan D Kirk

6

1 reference

11 August 2017

language of work or name

1 reference

1 September 2004

1 reference

11 August 2017

published in

Transplant Immunology

1 reference

11 August 2017

volume

13

1 reference

11 August 2017

issue

2

1 reference

11 August 2017

page(s)

87-99

1 reference

Improved graft survival after renal transplantation in the United States, 1988 to 1996

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Infectious complications in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Cancers in renal transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Lipid profile before and after renal transplantation--a longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Bone disease after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Calcineurin inhibitor nephrotoxicity: reduction in dose results in marked improvement in renal function in patients with coexisting chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

The natural history of chronic allograft nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

An innate sense of danger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

An innate sense of danger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Innate immune recognition: mechanisms and pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

The instructive role of innate immunity in the acquired immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Local synthesis of complement component C3 regulates acute renal transplant rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Natural adjuvants: endogenous activators of dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

The role of CD154 in organ transplant rejection and acceptance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Localization dose and time of antigens determine immune reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

The future of organ and tissue transplantation: can T-cell costimulatory pathway modifiers revolutionize the prevention of graft rejection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Memory T cells: a hurdle to immunologic tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Heterologous immunity: an overlooked barrier to tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Functions of CD40 on B cells, dendritic cells and other cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Regulatory T cells in transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Regulatory T cells and organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Regulatory T Cells in the Control of Transplantation Tolerance and Autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Challenges to achieving clinical transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Tolerance to vascularized organ allografts in large-animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

The role of peripheral T-cell deletion in transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Crossing the bridge: large animal models in translational transplantation research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

inferred from DOI database lookup

7 January 2021

based on heuristic

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Effects of dose and duration of anti-CD154 antibody therapy in preventing renal allograft rejection in a nonhuman primate model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Primate skin allotransplantation with anti-CD154 monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Effects of Combined Treatment with CD25- and CD154-Specific Monoclonal Antibodies in Non-Human Primate Allotransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Anti-CD40 therapy extends renal allograft survival in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Primate renal transplants using immunotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

FN18-CRM9 immunotoxin promotes tolerance in primate renal allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

The immune decision toward allograft tolerance in non-human primates requires early inhibition of innate immunity and induction of immune regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Preclinical evaluation of tolerance induction protocols and islet transplantation in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Costimulatory blockade for induction of mixed chimerism and renal allograft tolerance in nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Ethics in the quest for transplant tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

CAMPATH IH ALLOWS LOW-DOSE CYCLOSPORINE MONOTHERAPY IN 31 CADAVERIC RENAL ALLOGRAFT RECIPIENTS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Nonmyeloablative allogeneic stem cell transplant strategies and the role of mixed chimerism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

High-dose peripheral blood stem cell infusion: a strategy to induce donor-specific hyporesponsiveness to allografts in pediatric renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Inhibition of experimental drug allergy by prior feeding of the sensitizing agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

T-Cell Allorecognition and Transplant Rejection: A Summary and Update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

Immune profiling: molecular monitoring in renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.010

10.1016/J.TRIM.2004.05.010

7 January 2021

Identifiers

DOI

1 reference

11 August 2017

1 reference